Advances in markers of prodromal Parkinson disease
Authors:
- 27 October 2016
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neurology
- Vol. 12 (11) , 622-634
Abstract
Efforts to develop neuroprotective therapy for Parkinson disease (PD) are focusing on the early stages of disease, which offer the best opportunity to intervene. Early PD can be divided into preclinical, prodromal and clinical stages; in this Review, we focus on the prodromal stage and markers that can be used to identify prodromal PD. We consider the necessary properties of a marker, before providing an overview of the proven and potential markers of prodromal PD, including clinical nonmotor markers, clinical motor markers, neuroimaging markers and tissue biomarkers. Markers for which the ability to predict conversion to PD is supported by the strongest evidence include olfactory loss, REM sleep behaviour disorder and constipation. Markers with the highest diagnostic strength include REM sleep behaviour disorder, dopaminergic imaging and subtle motor parkinsonism. The lead time - the period between the appearance of a marker and conversion to PD - is highly variable between markers, ranging from 5 years for impaired motor performance to >20 years for autonomic symptoms. The cost of screening for these markers also varies dramatically: some require just questionnaires, whereas others require sophisticated scanning techniques. Finally, we summarize how prodromal and risk markers can be combined to estimate the probability that an individual has prodromal PD, with a focus on the International Parkinson Disease and Movement Disorders Society (MDS) Prodromal Parkinson Criteria.Keywords
This publication has 116 references indexed in Scilit:
- Meta‐analysis of early nonmotor features and risk factors for Parkinson diseaseAnnals of Neurology, 2012
- Olfactory discrimination predicts cognitive decline among community-dwelling older adultsTranslational Psychiatry, 2012
- Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: A population‐based studyAnnals of Neurology, 2011
- A Prospective Study of Bowel Movement Frequency and Risk of Parkinson's DiseaseAmerican Journal of Epidemiology, 2011
- Daytime Napping, Nighttime Sleeping, and Parkinson DiseaseAmerican Journal of Epidemiology, 2011
- Anxious personality predicts an increased risk of Parkinson's diseaseMovement Disorders, 2010
- Depression and the subsequent risk of Parkinson's disease in the NIH‐AARP Diet and Health StudyMovement Disorders, 2010
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- Neurodegenerative Diseases Target Large-Scale Human Brain NetworksNeuron, 2009
- Applicability of current staging/categorization of α-synuclein pathology and their clinical relevanceActa Neuropathologica, 2008